Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy
Clinical trial NCT02499224 · COMPLETED
Trial details
- NCT number
- NCT02499224
- Sponsor
- CellabMED
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2018-07-04
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.